**Systematic Review: Syndromes, Early Diagnosis, and ...



centertop00 Peer Reviewed Research on Mycophenolate Mofetil (cellcept) and Azathioprine (Imuran) are safe and effective for Autoimmune Encephalitis (*) denotes both medications included (**) denotes both medications listed with dose/frequency (***) only Mycophenotae Mofetil mentioned**Systematic Review: Syndromes, Early Diagnosis, and Treatment in Autoimmune Encephalitis by: Christina Hermetter,?Franz Fazekas, and?Sonja Hochmeister 2018(includes dose and frequency table 2) **Paraneoplastic and Other Autoimmune Disorders of the Central Nervous System by: Andrew McKeon 2013 (includes dose and frequency) **Autoimmune Encephalopathy (January 2019) Eoin P. Flanagan, M.B.B.Ch.; Richard J. Caselli, M.D. *Treatment strategies for autoimmune encephalitis (2017) *Antibody-Mediated Autoimmune Encephalopathies and ImmunotherapiesMatteo Gastaldi,? HYPERLINK "" Ana?s Thouin,and?Angela Vincent 2016 ** Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis (2011)Prof Josep Dalmau, MD,?Eric Lancaster, MD,?Eugenia Martinez-Hernandez, MD,?Prof Myrna R Rosenfeld, MD, andProf Rita Balice-Gordon, PhD **Anti–NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders (2011) *Autoimmune encephalitis (2016)M. P. Newman,S. Blum, R. C. W. Wong, J. G. Scott, K. Prain, R. J. Wilson, D. Gillis **Autoimmune Encephalitis: An update (2017) Satish Khadilkar, Girish Soni, Sarika Patil3, Abhinay Huchche, Hinaben Fal *Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study (2014) *An Update on the Treatment of Pediatric?Autoimmune Encephalitis.*Autoimmune encephalitis: Recent updates and emerging challenges (2014)*Immune therapy in autoimmune encephalitis: a systematic review (2015)***Cerebrospinal fluid CD19+?B‐cell expansion in?N‐methyl‐D‐aspartate receptor encephalitis (2012) (includes dose and frequency for Mycophenolate mofetil)***Mycophenolate mofetil?in paediatric autoimmune or immune-mediated diseases of the central nervous system: clinical experience and recommendations. Sept 2018 (includes dose and frequency) ***Myoclonic status epilepticus as a presentation of caspr2 antibody-associated?autoimmune encephalitis.(2014) **Diagnostic and therapeutic aspects of Hashimoto's encephalopathy (2013) ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download